GUO Yibing, WANG Shuiping, LIU Guowei, ZHOU Chengfu . Regulation Mechanisms of Berberine on Inflammatory Bowel Disease[J]. Chinese Journal of Animal Nutrition, 2018 , 30(11) : 4363 -4368 . DOI: 10.3969/j.issn.1006-267x.2018.11.012

[1] HABTEMARIAM S.Berberine and inflammatory bowel disease:a concise review[J].Pharmacological Research,2016,113:592-599.

[2] KUMAR A,EKAVALI,CHOPRA K,et al.Current knowledge and pharmacological profile of berberine:an update[J].European Journal of Pharmacology,2015,761:288-297.

[3] DE MATTOS B R R,GARCIA M P G,NOGUEIRA J B,et al.Inflammatory bowel disease:an overview of immune mechanisms and biological treatments[J].Mediators of Inflammation,2015,2015:493012.

[4] BERNSTEIN C N.Treatment of IBD:where we are and where we are going[J].The American Journal of Gastroenterology,2015,110(1):114-126.  

[5] BAUMGART D C,CARDING S R.Inflammatory bowel disease:cause and immunobiology[J].The Lancet,2007,369(9573):1627-1640.  

[6] PEDERSEN J,COSKUN M,SOENDERGAARD C,et al.Inflammatory pathways of importance for management of inflammatory bowel disease[J].World Journal of Gastroenterology,2014,20(1):64-77.  

[7] FONSECA-CAMARILLO G,YAMAMOTO-FURUSHO J K.Immunoregulatory pathways involved in inflammatory bowel disease[J].Inflammatory Bowel Diseases,2015,21(9):2188-2193.  

[8] KIM H J.Berberine ameliorates allodynia induced by chronic constriction injury of the sciatic nerve in rats[J].Journal of Medicinal Food,2015,18(8):909-915.  

[9] ZHOU X,YANG C,LI Y,et al.Potential of berberine to enhance antimicrobial activity of commonly used antibiotics for dairy cow mastitis caused by multiple drug-resistant Staphylococcus epidermidis infection[J].Genetics and Molecular Research,2015,14(3):9683-9692.  

[10] CHAE S H,JEONG I H,CHOI D H,et al.Growth-inhibiting effects of Coptis japonica root-derived isoquinoline alkaloids on human intestinal bacteria[J].Journal of Agricultural and Food Chemistry,999,47(3):934-938.

[11] LV Z,PENG G L,LIU W H,et al.Berberine blocks the relapse of Clostridium difficile infection in C57BL/6 mice after standard vancomycin treatment[J].Antimicrobial Agents and Chemotherapy,2015,59(7):3726-3735.  

[12] CHEN C Q,TAO C H,LIU Z C,et al.Randomized clinical trial of berberine hydrochloride in patients with diarrhea-predominant irritable bowel syndrome[J].Phytotherapy Research,2015,29(11):1822-1827.  

[13] HSU Y Y,TSENG Y T,LO Y C.Berberine,a natural antidiabetes drug,attenuates glucose neurotoxicity and promotes Nrf2-related neurite outgrowth[J].Toxicology and Applied Pharmacology,2013,272(3):787-796.  

[14] CHEN C Q,LU M L,PAN Q H,et al.Berberine improves intestinal motility and visceral pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome (IBS-D) symptoms in an opioid-receptor dependent manner[J].PLoS One,2015,10(12):e0145556.

[15] TANG Q L,LAI M L,ZHONG Y F,et al.Antinociceptive effect of berberine on visceral hypersensitivity in rats[J].World Journal of Gastroenterology,2013,19(28):4582-4589.  

[16] JIANG X W,ZHANG Y,ZHU Y L,et al.Effects of berberine gelatin on recurrent aphthous stomatitis:a randomized,placebo-controlled,double-blind trial in a Chinese cohort[J].Oral Surgery,Oral Medicine,Oral Pathology and Oral Radiology,2013,115(2):212-217.  

[17] 王祖浩,郭勇,周美含,等.榛仁五肽对HUVEC细胞氧化应激损伤的保护作用[J].现代食品科技,2018,34(3):1-7.

[18] 汪水平,王文娟,彭希豪,等.盐酸小檗碱对肉兔脂质代谢、内分泌及抗氧化功能的影响[J].畜牧兽医学报,2013,44(5):745-753.

[19] MCCUBREY J A,LERTPIRIYAPONG K,STEELMAN L S,et al.Regulation of GSK-3 activity by curcumin,berberine and resveratrol:potential effects on multiple diseases[J].Advances in Biological Regulation,2017,65:77-88.

[20] DANIEL B,KONRAD B,TOPLAK M,et al.The family of berberine bridge enzyme-like enzymes:a treasure-trove of oxidative reactions[J].Archives of Biochemistry and Biophysics,2017,632:88-103.

[21] SIOW Y L,SARNA L,KARMIN O.Redox regulation in health and disease-therapeutic potential of berberine[J].Food Research International,2011,44(8):2409-2417.  

[22] MISTRY B M,SHIN H S,KEUM Y S,et al.Synthesis and evaluation of antioxidant and cytotoxicity of the N-mannich base of berberine bearing benzothiazole moieties[J].Anti-Cancer Agents in Medicinal Chemistry,2017,17(12):1652-1660.

[23] DIGUILIO K M,MERCOGLIANO C M,BORN J,et al.Sieving characteristics of cytokine-and peroxide-induced epithelial barrier leak:inhibition by berberine[J].World Journal of Gastrointestinal Pathophysiology,2016,7(2):223-234.  

[24] AMASHEH M,FROMM A,KRUG S M,et al.TNFα-induced and berberine-antagonized tight junction barrier impairment via tyrosine kinase,Akt and NFκB signaling[J].Journal of Cell Science,2010,123(23):4145-4155.  

[25] HAO X H,YAO A L,GONG J F,et al.Berberine ameliorates pro-inflammatory cytokine-induced endoplasmic reticulum stress in human intestinal epithelial cells in vitro[J].Inflammation,2012,35(3):841-849.  

[26] LI G X,WANG X M,JIANG T,et al.Berberine prevents damage to the intestinal mucosal barrier during early phase of sepsis in rat through mechanisms independent of the NOD-like receptors signaling pathway[J].European Journal of Pharmacology,2014,730:1-7.

[27] GU L L,LI N,GONG J F,et al.Berberine ameliorates intestinal epithelial tight-junction damage and down-regulates myosin light chain kinase pathways in a mouse model of endotoxinemia[J].The Journal of Infectious Diseases,2011,203(11):1602-1612.  

[28] TAN S J,YU W K,LIN Z L,et al.Berberine ameliorates intestinal mucosal barrier damage induced by peritoneal air exposure[J].Biological and Pharmaceutical Bulletin,2015,38(1):122-126.  

[29] LI Y H,XIAO H T,HU D D,et al.Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses[J].Pharmacological Research,2016,110:227-239.

[30] MOGENSEN T H.Pathogen recognition and inflammatory signaling in innate immune defenses[J].Clinical Microbiology Reviews,2009,22(2):240-273.  

[31] LI C Z,XI Y B,LI S,et al.Berberine ameliorates TNBS induced colitis by inhibiting inflammatory responses and Th1/Th17 differentiation[J].Molecular Immunology,2015,67(2):444-454.  

[32] KAWANO K,TAKAGI R,KANEKO A,et al.Berberine is a dopamine D1-and D2-like receptor antagonist and ameliorates experimentally induced colitis by suppressing innate and adaptive immune responses[J].Journal of Neuroimmunology,2015,289:43-55.

[33] KUO C L,CHI C W,LIU T Y.The anti-inflammatory potential of berberine in vitro and in vivo[J].Cancer Letters,2004,203(2):127-137.  

[34] CǎTANǎ C S,BERINDAN-NEAGOE I,COZMA V,et al.Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease[J].World Journal of Gastroenterology,2015,21(19):5823-5830.  

[35] YANG J F,SUNDRUD M S,SKEPNER J,et al.Targeting Th17 cells in autoimmune diseases[J].Trends in Pharmacological Sciences,2014,35(10):493-500.  

[36] QIN X,GUO B T,WAN B,et al.Regulation of Th1 and Th17 cell differentiation and amelioration of experimental autoimmune encephalomyelitis by natural product compound berberine[J].Journal of Immunology,2010,185(3):1855-1863.  

[37] CUI G L,QIN X,ZHANG Y B,et al.Berberine differentially modulates the activities of ERK,p38 MAPK,and JNK to suppress Th17 and Th1 T cell differentiation in type 1 diabetic mice[J].Journal of Biological Chemistry,2009,284(41):28420-28429.  

[38] LI H,LI X L,ZHANG M,et al.Berberine ameliorates experimental autoimmune neuritis by suppressing both cellular and humoral immunity[J].Scandinavian Journal of Immunology,2014,79(1):12-19.